GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_616/2025

GlaxoSmithKline Biologicals SA v. Moderna Netherlands B.V., Moderna Biotech Spain, S.L., Moderna Biotech UK Limited, Moderna Biotech Distributor UK Ltd, Moderna Switzerland GmbH, Moderna Poland SP. Z.O.O., Moderna, Inc., ModernaTX, Inc., Moderna Belgium S.R.L., Moderna France SASU, Moderna Germany GmbH, Moderna Italy S.R.L., Moderna Portugal Unipessoal LDA, Moderna Sweden AB, Moderna Norway A/S

Datum
2026-09-14
Kammer
The Hague (NL) Local Division
Verfahrensart
Infringement
Sprache
EN

Metadaten

Fall-IDUPC_CFI_616-2025-580b3daae2a7
Aktenzeichen
RegisterzeichenUPC_CFI_616/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

1 The Hague - Local Division UPC_CFI_616/2025 UPC_CFI_1439/2025 Order of the Court of First Instance of the Unified Patent Court delivered on 11/09/2026 CLAIMANT/DEFENDANT IN THE COUNTERCLAIM 1) GlaxoSmithKline Biologicals SA (Claimant) - Rue de l'Institut 89 - 1330 - Rixensart - BE Represented by Tjibbe Douma, Carlos van Staveren, Nicole Jadeja and Emilia Zalewska of Bird & Bird LLP DEFENDANTS/COUNTERCLAIMANTS 1) Moderna Netherlands B.V. Claude Debussylaan 7 - 1082 MC - Amsterdam - NL 2) Moderna Biotech Spain, S.L. C/Julián Camarillo 31 - 28037 - Madrid - ES 3) Moderna Biotech UK Limited 54 Portland Place - W1B 1DY - London - GB 4) Moderna Biotech Distributor UK Ltd MYO, 123 Victoria Street - SW1E 6DE - London - GB 2 5) Moderna Switzerland GmbH (Defendant) - Peter Merian-Weg 10 - 4052 - B ...